However, some caution should be exercised about this viewpoint regarding the use of SOCC blockers in the treatment of pulmonary hypertension because Gd3+, unlike SK, was unable to block the ET‐1‐induced increase in [Ca2+]i in VSMC. This evidence concerns the gene EDN1 and pulmonary arterial hypertension.